Recent publications in respected journals have unveiled startling evidence that antipsychotic medications, championed by many in the mental health field, could be reducing brain volume by 8 to 11 percent. These findings cast doubt on the pharmaceutical industry-sponsored narrative around the 'chemical imbalance' theory of mental illness and highlight the risks of an unchecked push toward medication over alternative treatments. Critics are calling for a reevaluation of psychiatric care practices, emphasizing personal responsibility and the potential consequences of dependency on pharmaceutical solutions.
Overreliance on Prescription Psychotropics Exposed: Study Reveals Brain Shrinkage Risk
All Versions
Jan-17
Health
Score: 0.55
Brain Volume Reduction: Psychotropic drugs can reduce brain volume by 8 to 11 percent, as revealed in studies on Macaque monkeys published in PubMed and the journal Nature. Misleading “Chemical Imbalance” Theory: The concept of a “chemical imbalance” in menta…
From Naturalnews.com
Jan-17
Health
Left Variant
Score: 0.20
New, peer-reviewed research raises alarming questions about the safety of widely-used antipsychotic medications, indicating potential brain volume decreases of up to 11 percent. This groundbreaking study challenges the pharmaceutical industry's long-standing defense of psychotropic drugs based on the debatable 'chemical imbalance' theory. Advocates are now urging for a comprehensive review of psychiatric medication practices, demanding greater transparency and patient safety in a field too often influenced by big pharma's profit motives.
From Naturalnews.com